Accumulation of oxidative stress around the stroke-like lesions of MELAS patients

Mitochondrion

Volumn 9, Issue 5, 2009, Pages 306-313

  Katayama, Yuri ^a   Maeda, Kengo ^a   Iizuka, Takahiro ^b   Hayashi, Masaharu ^c   Hashizume, Yoshio ^d   Sanada, Mitsuru ^a   Kawai, Hiromichi ^a   Kashiwagi, Atsunori ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

8 hydroxy 2 deoxyguanosine; Edaravone; Manganese superoxide dismutase; MELAS; Oxidative stress; Stroke like episode

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; DNA; MANGANESE SUPEROXIDE DISMUTASE; NORPHENAZONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN NERVE CELL; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ELECTRON MICROSCOPY; FEMALE; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MELAS SYNDROME; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STROKE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPYRINE; DEOXYGUANOSINE; DNA GLYCOSYLASES; FEMALE; FREE RADICAL SCAVENGERS; HISTOCYTOCHEMISTRY; HUMANS; MALE; MELAS SYNDROME; MIDDLE AGED; NEURONS; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; YOUNG ADULT;

EID: 70149105914     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2009.04.002     Document Type: Article

References (75)

1. Abe K., Yuki S., and Kogure K. Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 19 (1988) 480-485
2. Aguirre N., Beal M.F., Matson W.R., and Bogdanov M.B. Increased oxidative damage to DNA in an animal model of amyotrophic lateral sclerosis. Free Radic. Res. 39 (2005) 383-388
3. Bogdanov M.B., Andreassen O.A., Dedeoglu A., Ferrante R.J., and Beal M.F. Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease. J. Neurochem. 79 (2001) 1246-1249
4. Candelario-Jalil E., Mhadu N.H., Al-Dalain S.M., Martínez G., and León O.S. Time course of oxidative damage in different brain regions following transient cerebral ischemia in gerbils. Neurosci. Res. 41 (2001) 233-241
5. Chan P.H. Role of oxidants in ischemic brain damage. Stroke 27 (1996) 1124-1129
6. Chinnery P.F., Howell N., Lightowlers R.N., and Turnbull D.M. Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain 120 (1997) 1713-1721
7. Clark J.M., Marks M.P., Adalsteinsson E., Spielman D.M., Shuster D., Horoupian D., and Albers G.W. MELAS: clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy. Neurology 46 (1996) 223-227
8. Coyle J.T., and Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262 (1993) 689-695
9. Culotta V.C., Yang M., and O'Halloran T.V. Activation of superoxide dismutases: putting the metal to the pedal. Biochim. Biophys. Acta 1763 (2006) 747-758
10. DiMauro S., and Mancuso M. Mitochondrial diseases: therapeutic approaches. Biosci. Rep. 27 (2007) 125-137
11. DiMauro S., Hirano M., and Schon E.A. Mitochondrial encephalomyopathies: therapeutic approaches. Neurol. Sci. 21 (2000) S901-S908
12. DiMauro S., Mancuso M., and Naini A. Mitochondrial encephalomyopathies: therapeutic approach. Ann. NY. Acad. Sci. 1011 (2004) 232-245
13. DiMauro S., Hirano M., and Schon E.A. Approaches to the treatment of mitochondrial diseases. Muscle Nerve 34 (2006) 265-283
14. Ferrante R.J., Browne S.E., Shinobu L.A., Bowling A.C., Baik M.J., MacGarvey U., Kowall N.W., Brown Jr. R.H., and Beal M.F. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 69 (1997) 2064-2074
15. Finsterer J. Central nervous system manifestations of mitochondrial disorders. Acta Neurol. Scand. 114 (2006) 217-238
16. Folkerth R.D., Haynes R.L., Borenstein N.S., Belliveau R.A., Trachtenberg F., Rosenberg P.A., Volpe J.J., and Kinney H.C. Developmental lag in superoxide dismutases relative to other antioxidant enzymes in premyelinated human telencephalic white matter. J. Neuropathol. Exp. Neurol. 63 (2004) 990-999
17. Fraga C.G., Shigenaga M.K., Park J.W., Degan P., and Ames B.N. Oxidative damage to DNA during aging: 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc. Natl. Acad. Sci. USA 87 (1990) 4533-4537
18. Gilchrist J.M., Sikirica M., Stopa E., and Shanske S. Adult-onset MELAS. Evidence for involvement of neurons as well as cerebral vasculature in strokelike episodes. Stroke 27 (1996) 1420-1423
19. Goto Y., Nonaka I., and Horai S. A mutation in the tRNA (Leu) (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348 (1990) 651-653
20. Goto Y., Nonaka I., and Horai S. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim. Biophys. Acta 1097 (1991) 238-240
21. Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc. Dis. 15 (2003) 222-229
22. Hersch S.M., Gevorkian S., Marder K., Moskowitz C., Feigin A., Cox M., Como P., Zimmerman C., Lin M., Zhang L., Ulug A.M., Beal M.F., Matson W., Bogdanov M., Ebbel E., Zaleta A., Kaneko Y., Jenkins B., Hevelone N., Zhang H., Yu H., Schoenfeld D., Ferrante R., and Rosas H.D. Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG. Neurology 66 (2006) 250-252
23. Hirano M., and Pavlakis S.G. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J. Child Neurol. 9 (1994) 4-13
24. Ichiki T., Tanaka M., Nishikimi M., Suzuki H., Ozawa T., Kobayashi M., and Wada Y. Deficiency of subunits of complex I and mitochondrial encephalomyopathy. Ann. Neurol. 23 (1988) 287-294
25. Iizuka T., and Sakai F. Pathogenesis of stroke-like episodes in MELAS: analysis of neurovascular cellular mechanisms. Curr. Neurovasc. Res. 2 (2005) 29-45
26. Iizuka T., Sakai F., Suzuki N., Hata T., Tsukahara S., Fukuda M., and Takiyama Y. Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology 59 (2002) 816-824
27. Iizuka T., Sakai F., Kan S., and Suzuki N. Slowly progressive spread of the stroke-like lesions in MELAS. Neurology 61 (2003) 1238-1244
28. Iizuka T., Sakai F., Ide T., Miyakawa S., Sato M., and Yosii S. Regional cerebral blood flow and cerebrovascular reactivity during chronic stage of stroke-like episodes in MELAS - implication of neurovascular cellular mechanism. J. Neurol. Sci. 257 (2007) 126-138
29. Jarrett S.G., Liang L.P., Hellier J.L., Staley K.J., and Patel M. Mitochondrial DNA damage and impaired base excision repair during epileptogenesis. Neurobiol. Dis. 30 (2008) 130-138
30. Kaufmann P., Shungu D.C., Sano M., Jhung S., Engelstad K., Mitsis E., Mao X., Shanske S., Hirano M., DiMauro S., and De Vivo D.C. Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology 62 (2004) 1297-1302
31. Kawai H., Nakai H., Suga M., Yuki S., Watanabe T., and Saito K.I. Effects of a novel free radical scavenger, MCl-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J. Pharmacol. Exp. Ther. 281 (1997) 921-927
32. Kim G.W., Kondo T., Noshita N., and Chan P.H. Manganese superoxide dismutase deficiency exacerbates cerebral infarction after focal cerebral ischemia/reperfusion in mice: implications for the production and role of superoxide radicals. Stroke 33 (2002) 809-815
33. King M.P., Koga Y., Davidson M., and Schon E.A. Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA (Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Mol. Cell. Biol. 12 (1992) 480-490
34. Kobayashi M., Morishita H., Sugiyama N., Yokochi K., Nakano M., and Wada Y. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes syndrome and NADH-CoQ reductase deficiency. J. Inherit. Metab. Dis. 9 (1986) 301-304
35. Kobayashi M., Morishita H., Sugiyama N., Yokochi K., Nakano M., and Wada Y. Two cases of NADH-coenzyme Q reductase deficiency: relationship to MELAS syndrome. J. Pediatr. 110 (1987) 223-227
36. Koga Y., Ishibashi M., Ueki I., Yatsuga S., Fukiyama R., Akita Y., and Matsuishi T. Effects of l-arginine on the acute phase of strokes in three patients with MELAS. Neurology 58 (2002) 827-828
37. Koga Y., Akita Y., Nishioka J., Yatsuga S., Povalko N., Tanabe Y., Fujimoto S., and Matsuishi T. l-arginine improves the symptoms of strokelike episodes in MELAS. Neurology 64 (2005) 710-712
38. Koga Y., Akita Y., Nishioka J., Yatsuga S., Povalko N., Fukiyama R., Ishii M., and Matsuishi T. Endothelial dysfunction in MELAS improved by l-arginine supplementation. Neurology 66 (2006) 1766-1769
39. Koga Y., Akita Y., Nishioka J., Yatsuga S., Povalko N., Katayama K., and Matsuishi T. MELAS and l-arginine therapy. Mitochondrion 7 (2007) 133-139
40. Kovács R., Schuchmann S., Gabriel S., Kann O., Kardos J., and Heinemann U. Free radical-mediated cell damage after experimental status epilepticus in hippocampal slice cultures. J. Neurophysiol. 88 (2002) 2909-2918
41. Liang L.P., and Patel M. Mitochondrial oxidative stress and increased seizure susceptibility in Sod2(-/+) mice. Free Radic. Biol. Med. 36 (2004) 542-554
42. Liang L.P., Ho Y.S., and Patel M. Mitochondrial superoxide production in kainate-induced hippocampal damage. Neuroscience 101 (2000) 563-570
43. Maeda K., Tatsumi M., Tahara M., Murata Y., Kawai H., and Yasuda H. A case of stroke-like episode of MELAS of which progressive spread would be prevented by edaravone. Clin. Neurol. 45 (2005) 416-421
44. Mecocci P., Beal M.F., Cecchetti R., Polidori M.C., Cherubini A., Chionne F., Avellini L., Romano G., and Senin U. Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain. Mol. Chem. Neuropathol. 31 (1997) 53-64
45. Morgan-Hughes J.A., and Hanna M.G. Mitochondrial encephalomyopathies: the enigma of genotype versus phenotype. Biochim. Biophys. Acta 1410 (1999) 125-145
46. Nagayama T., Lan J., Henshall D.C., Chen D., O'Horo C., Simon R.P., and Chen J. Induction of oxidative DNA damage in the peri-infarct region after permanent focal cerebral ischemia. J. Neurochem. 75 (2000) 1716-1728
47. Nishi H., Watanabe T., Sakurai H., Yuki S., and Ishibashi A. Effect of MCI-186 on brain edema in rats. Stroke 20 (1989) 1236-1240
48. Nunomura A., Perry G., Pappolla MA., Wade R., Hirai K., Chiba S., and Smith MA. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci. 19 (1999) 1959-1964
49. Ohama E., Ohara S., Ikuta F., Tanaka K., Nishizawa M., and Miyatake T. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol. 74 (1987) 226-233
50. Ohtaki H., Takeda T., Dohi K., Yofu S., Nakamachi T., Satoh K., Hiraizumi Y., Miyaoka H., Matsunaga M., and Shioda S. Increased mitochondrial DNA oxidative damage after transient middle cerebral artery occlusion in mice. Neurosci. Res. 58 (2007) 349-355
51. Pang C.Y., Lee H.C., and Wei Y.H. Enhanced oxidative damage in human cells harboring A3243G mutation of mitochondrial DNA: implication of oxidative stress in the pathogenesis of mitochondrial diabetes. Diabetes Res. Clin. Pract. 54 (2001) S45-S56
52. Patel M. Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Radic. Biol. Med. 37 (2004) 1951-1962
53. Pavlakis S.G., Phillips P.C., DiMauro S., De Vivo D.C., and Rowland L.P. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann. Neurol. 16 (1984) 481-488
54. Rusanen H., Majamaa K., and Hassinen I.E. Increased activities of antioxidant enzymes and decreased ATP concentration in cultured myoblasts with the 3243A -->G mutation in mitochondrial DNA. Biochim. Biophys. Acta 1500 (2000) 10-16
55. Sakuta R., and Nonaka I. Vascular involvement in mitochondrial myopathy. Ann. Neurol. 25 (1989) 594-601
56. Sandhu J.K., Sodja C., McRae K., Li Y., Rippstein P., Wei Y.H., Lach B., Lee F., Bucurescu S., Harper M.E., and Sikorska M. Effects of nitric oxide donors on cybrids harbouring the mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) A3243G mitochondrial DNA mutation. Biochem. J. 391 (2005) 191-202
57. Sato S., Mizuno Y., and Hattori N. Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease. Neurology 64 (2005) 1081-1083
58. Scaglia F., and Northrop J.L. The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options. CNS Drugs 20 (2006) 443-464
59. Seki S., Kitada T., Sakaguchi H., Nakatani K., and Wakasa K. Pathological significance of oxidative cellular damage in human alcoholic liver disease. Histopathology 42 (2003) 365-371
60. Sparaco M., Bonilla E., DiMauro S., and Powers J.M. Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J. Neuropathol. Exp. Neurol. 52 (1993) 1-10
61. Sugimoto K., Nishizawa Y., Horiuchi S., and Yagihashi S. Localization in human diabetic peripheral nerve of N(epsilon)-carboxymethyllysine-protein adducts, an advanced glycation end product. Diabetologia 40 (1997) 1380-1387
62. Takamatsu Y., and Watanabe T. Studies on the concentrations of 3-methyl-1-phenyl- 2-pyrazolin-5-one (MCI-186) in dog plasma and cerebral spinal fluid. Jpn. Pharmacol. Ther. 25 suppl (1997) 1793-1797
63. Tanahashi C., Nakayama A., Yoshida M., Ito M., Mori N., and Hashizume Y. MELAS with the mitochondrial DNA 3243 point mutation: a neuropathological study. Acta Neuropathol. 99 (2000) 31-38
64. Terauchi A., Tamagawa K., Morimatsu Y., Kobayashi M., Sano T., and Yoda S. An autopsy case of mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) with a point mutation of mitochondrial DNA. Brain Dev. 18 (1996) 224-229
65. Vives-Bauza C., Gonzalo R., Manfredi G., Garcia-Arumi E., and Andreu A.L. Enhanced ROS production and antioxidant defenses in cybrids harbouring mutations in mtDNA. Neurosci. Lett. 391 (2006) 136-141
66. Vladimirova O., O'Connor J., Cahill A., Alder H., Butunoi C., and Kalman B. Oxidative damage to DNA in plaques of MS brains. Mult. Scler. 4 (1998) 413-418
67. Wang, A.L., Lukas, T.J., Yuan, M., Neufeld, AH., 2008. Age-related increase in mitochondrial DNA damage and loss of DNA repair capacity in the neural retina. Neurobiol Aging. Epub ahead of print.
68. Watanabe T., and Egawa M. Effects of an antistroke agent MCl-186 on cerebral arachidonate cascade. J. Pharmacol. Exp. Ther. 271 (1994) 1624-1629
69. Watanabe T., Yuki S., Egawa M., and Nishi H. Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J. Pharmacol. Exp. Ther. 268 (1994) 1597-1604
70. Wei Y.H., Lu C.Y., Wei C.Y., Ma Y.S., and Lee H.C. Oxidative stress in human aging and mitochondrial disease-consequences of defective mitochondrial respiration and impaired antioxidant enzyme system. Clin. J. Physiol. 44 (2001) 1-11
71. Yamamoto Y., Kuwahara T., Watanabe K., and Watanabe K. Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one. Redox Rep. 2 (1996) 333-338
72. Yamamoto T., Yuki S., Watanabe T., Mitsuka M., Saito K.I., and Kogure K. Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia. Brain Res. 762 (1997) 240-242
73. Yoneda M., Maeda M., Kimura H., Fujii A., Katayama K., and Kuriyama M. Vasogenic edema on MELAS: a serial study with diffusion-weighted MR imaging. Neurology 53 (1999) 2182-2184
74. Yoshida H., Yanai H., Namiki Y., Fukatsu-Sasaki K., Furutani N., and Tada N. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev. 12 (2006) 9-20
75. Zhang N., Komine-Kobayashi M., Tanaka R., Liu M., Mizuno Y., and Urabe T. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 36 (2005) 2220-2225